GlassScriptPhysician profile
Steven Lee Willett
NPI 1194749689
$791.92
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $68.46 · 2021: $69.02 · 2022: $110 · 2023: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $291.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $200.24 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $143.32 | 2019-2023 | Myrbetriq, Veozah |
| Gynesonics, INC. | $121.83 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Therapeuticsmd, INC. | $96.86 | 2019-2022 | |
| Avion Pharmaceuticals | $52.47 | 2019-2023 | Balcoltra |
| Hologic Sales and Service, LLC | $44.53 | 2023 | Acessa Provu System, Thinprep 2000 Processor, Aptima |
| Pfizer INC. | $38.95 | 2021-2022 | |
| Duchesnay USA Incorporated | $31.81 | 2019-2020 | |
| Daiichi Sankyo INC. | $20.74 | 2021 | |
| Sumitomo Pharma America, INC. | $14.53 | 2023 | Myfembree |
| Lupin INC. | $13.44 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Willett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.